The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain
Public ClinicalTrials.gov record NCT00376454. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Tolerability of a 14 Day Treatment Course of GW493838 50mg Compared to Placebo in Subjects With Peripheral Neuropathic Pain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to determine the analgesic effect of GW493838 in patients with post-herpetic neuralgia or peripheral nerve injury caused by trauma or surgery.
Study identification
- NCT ID
- NCT00376454
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 113 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2002 (Type not available)
- Primary completion
- Jun 2003 (Actual)
- Completion
- Jun 2003 (Actual)
- Last update posted
- Feb 12, 2013
2002 – 2003
United States locations
- U.S. sites
- 32
- U.S. states
- 20
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Clinical Trials Call Center | Huntsville | Alabama | 35801 | — |
| GSK Clinical Trials Call Center | Hot Springs | Arizona | 71913 | — |
| GSK Clinical Trials Call Center | Little Rock | Arkansas | 72205 | — |
| GSK Clinical Trials Call Center | La Jolla | California | 92037 | — |
| GSK Clinical Trials Call Center | Oceanside | California | 92056 | — |
| GSK Clinical Trials Call Center | Boulder | Colorado | 80304 | — |
| GSK Clinical Trials Call Center | Fort Lauderdale | Florida | 33308 | — |
| GSK Clinical Trials Call Center | Fort Myers | Florida | 33916 | — |
| GSK Clinical Trials Call Center | Palm Beach | Florida | 33409 | — |
| GSK Clinical Trials Call Center | Palm Beach Gardens | Florida | 33410 | — |
| GSK Clinical Trials Call Center | Pembroke Pines | Florida | 33024 | — |
| GSK Clinical Trials Call Center | South Daytona | Florida | 32119 | — |
| GSK Clinical Trials Call Center | St. Petersburg | Florida | 33701 | — |
| GSK Clinical Trials Call Center | West Palm Beach | Florida | 33407 | — |
| GSK Clinical Trials Call Center | Evansville | Indiana | 47712 | — |
| GSK Clinical Trials Call Center | Lexington | Kentucky | 40503 | — |
| GSK Clinical Trials Call Center | Louisville | Kentucky | 40202 | — |
| GSK Clinical Trials Call Center | Louisville | Kentucky | 40205 | — |
| GSK Clinical Trials Call Center | Covington | Louisiana | 70433 | — |
| GSK Clinical Trials Call Center | Boston | Massachusetts | 02115 | — |
| GSK Clinical Trials Call Center | Henderson | Nevada | 89052 | — |
| GSK Clinical Trials Call Center | Lebanon | New Hampshire | 03766 | — |
| GSK Clinical Trials Call Center | Ridgewood | New Jersey | 07450 | — |
| GSK Clinical Trials Call Center | Albany | New York | 12205 | — |
| GSK Clinical Trials Call Center | Asheville | North Carolina | 28803 | — |
| GSK Clinical Trials Call Center | Winston-Salem | North Carolina | 27103 | — |
| GSK Clinical Trials Call Center | Tulsa | Oklahoma | 74104 | — |
| GSK Clinical Trials Call Center | Altoona | Pennsylvania | 16601 | — |
| GSK Clinical Trials Call Center | Duncansville | Pennsylvania | 16635 | — |
| GSK Clinical Trials Call Center | Richardson | Texas | 75080 | — |
| GSK Clinical Trials Call Center | Tacoma | Washington | 98405 | — |
| GSK Clinical Trials Call Center | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00376454, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 12, 2013 · Synced Nov 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00376454 live on ClinicalTrials.gov.